Social Media Newsroom

About

Creative Biolabs headquartered in New York, US, is a global leader in providing CRO services for SARS-CoV-2 vaccine design, development, optimization, and qualification. The company is also involved in in vitro diagnostic (IVD) reagent development and novel drug discovery through cutting-edge technologies and facilities. Creative Biolabs delivers a wide range of products and protocols in past years to worldwide researchers to accelerate the fight against the COVID-19 pandemic.

Connect

Press Contact

Name
Candy Swift
Phone
1-631-830-6441
Email
Contact Us
Website
https://sars-cov-2.creative-biolabs.com

Press Releases

Creative Biolabs Expedites SARS-CoV-2 Subunit Vaccine Development as Variants Arise

More Released on October 18, 2022

Creative Biolabs Echoes White House's Efforts in Next-Generation COVID-19 Vaccine Development

More Released on August 30, 2022